Tobias Saueressig

Tobias Saueressig

Auto-generated profile, based on publicly available information

Tobias Saueressig

Physio Meets Science GmbH, Leimen, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2023 in Sports Medicine
Verified
Journal Article
Closed access
PDF file
BPBabette M. Pluim
Babette M. Pluim
MJMarleen G. T. Jansen
Marleen G. T. Jansen
SWSamuel Williamson
Samuel Williamson
CBCain Berry
Cain Berry
SCSilvia Camporesi
Silvia Camporesi
CAClare L. Ardern
Clare L. Ardern

1 February 2021 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
TSTobias Saueressig
Tobias Saueressig
POPatrick Owen
Patrick Owen
JZJochen Zebisch
Jochen Zebisch
MHMaximilian Herbst
Maximilian Herbst
DBDaniel L. Belavy
Daniel L. Belavy
Osteoarthritis is one of the leading causes of pain, disability, and health care resource use worldwide.1 While the disease can affect any joint, the hip is among the most common sites.2,3 There is a growing concern that the incidence, in part owing to the aging population, and subsequent financial burden at both the individual and societal level will continue to increase.1,3

29 August 2022 in British Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
TSTobias Saueressig
Tobias Saueressig
TBTobias Braun
Tobias Braun
NSNora Steglich
Nora Steglich
FDFrank Diemer
Frank Diemer
JZJochen Zebisch
Jochen Zebisch
DBDaniel Belavy
Daniel Belavy
Objective Compare the effectiveness of primarily surgical versus primarily rehabilitative management for anterior cruciate ligament (ACL) rupture. Design Living systematic review and meta-analysis. Data sources Six databases, six trial registries and prior systematic reviews. Forward and backward citation tracking was employed. Eligibility criteria Randomised controlled trials that compared primary reconstructive surgery and primary rehabilitative treatment with or without optional reconstructive surgery. Data synthesis Bayesian random effects meta-analysis with empirical priors for the OR and standardised mean difference and 95% credible intervals (CrI), Cochrane RoB2, and the Grading of Recommendations Assessment, Development and Evaluation approach to judge the certainty of evidence. Results Of 9514 records, 9 reports of three studies (320 participants in total) were included. No clinically important differences were observed at any follow-up for self-reported knee function (low to very low certainty of evidence). For radiological knee osteoarthritis, we found no effect at very low certainty of evidence in the long term (OR (95% CrI): 1.45 (0.30 to 5.17), two studies). Meniscal damage showed no effect at low certainty of evidence (OR: 0.85 (95% CI 0.45 to 1.62); one study) in the long term. No differences were observed between treatments for any other secondary outcome. Three ongoing randomised controlled trials were identified. Conclusions There is low to very low certainty of evidence that primary rehabilitation with optional surgical reconstruction results in similar outcome measures as early surgical reconstruction for ACL rupture. The findings challenge a historical paradigm that anatomic instability should be addressed with primary surgical stabilisation to provide optimal outcomes. PROSPERO registration number CRD42021256537.

20 December 2023 in European journal of pain
Verified
Journal Article
Open access
TSTobias Saueressig
Tobias Saueressig
POPatrick Owen
Patrick Owen
HPHugo Pedder
Hugo Pedder
STScott Tagliaferri
Scott Tagliaferri
SKSvenja Kaczorowski
Svenja Kaczorowski
DBDaniel Belavy
Daniel Belavy
Background and Objective: Contextual effects (e.g. patient expectations) may play a role in treatment effectiveness. This study aimed to estimate the magnitude of contextual effects for conservative, non‐pharmacological interventions for musculoskeletal pain conditions. A systematic review and meta‐analysis of randomized controlled trials (RCTs) that compared placebo conservative non‐pharmacological interventions to no treatment for musculoskeletal pain. The outcomes assessed included pain intensity, physical functioning, health‐related quality of life, global rating of change, depression, anxiety and sleep at immediate, short‐, medium‐ and/or long‐term follow‐up.Databases and Data Treatment: MEDLINE, EMBASE, CINAHL, Web of Science Core Collection, CENTRAL and SPORTDiscus were searched from inception to September 2021. Trial registry searches, backward and forward citation tracking and searches for prior systematic reviews were completed. The Cochrane risk of bias 2 tool was implemented.Results: The study included 64 RCTs (N = 4314) out of 8898 records. For pain intensity, a mean difference of (MD: −5.32, 95% confidence interval (CI): −7.20, −3.44, N = 57 studies with 74 outcomes, GRADE: very low) was estimated for placebo interventions. A small effect in favour of the placebo interventions for physical function was estimated (SMD: −0.22, 95% CI: −0.35, −0.09; N = 37 with 48 outcomes, GRADE: very low). Similar results were found for a broad range of patient‐reported outcomes. Meta‐regression analyses did not explain heterogeneity among analyses.Conclusion: The study found that the contextual effect of non‐pharmacological conservative interventions for musculoskeletal conditions is likely to be small. However, given the known effect sizes of recommended evidence‐based treatments for musculoskeletal conditions, it may still contribute an important component.Significance: Contextual effects of non‐pharmacological conservative interventions for musculoskeletal conditions are likely to be small for a broad range of patient‐reported outcomes (pain intensity, physical function, quality of life, global rating of change and depression). Contextual effects are unlikely, in isolation, to offer much clinical care. But these factors do have relevance in an overall treatment context as they provide almost 30% of the minimally clinically important difference.

13 February 2024 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
TSTobias Saueressig
Tobias Saueressig
HPHugo Pedder
Hugo Pedder
POPatrick Owen
Patrick Owen
DBDaniel Belavy
Daniel Belavy
The importance of contextual effects and their roles in clinical care controversial. A Cochrane review published in 2010 concluded that placebo interventions lack important clinical effects overall, but that placebo interventions can influence patient-reported outcomes such as pain and nausea. However, systematic reviews published after 2010 estimated greater contextual effects than the Cochrane review, which stems from the inappropriate methods employed to quantify contextual effects. The effects of medical interventions (i.e., the total treatment effect) can be divided into three components: specific, contextual, and non-specific. We propose that the most effective method for quantifying the magnitude of contextual effects is to calculate the difference in outcome measures between a group treated with placebo and a non-treated control group. Here, we show that other methods, such as solely using the placebo control arm or calculation of a ‘proportional contextual effect,’ are limited and should not be applied. The aim of this study is to provide clear guidance on best practices for estimating contextual effects in clinical research.

14 December 2023 in Sports Medicine
Verified
Journal Article
Open access
PDF file
NANitin Kumar Arora
Nitin Kumar Arora
LDLars Donath
Lars Donath
POPatrick Owen
Patrick Owen
CMClint T. Miller
Clint T. Miller
TSTobias Saueressig
Tobias Saueressig
DBDaniel Belavy
Daniel Belavy
Background: Musculoskeletal pain conditions are the largest contributors to disability and healthcare burden globally. Exercise interventions improve physical function and quality of life in individuals with musculoskeletal pain, yet optimal exercise prescription variables (e.g. duration, frequency, intensity) are unclear. Objective: We aimed to examine evidence gaps, methodological quality and exercise prescription recommendations in systematic reviews of exercise for musculoskeletal pain. Methods: In our prospectively registered umbrella review, PubMed, SPORTDiscus, Cochrane Database of Systematic Reviews, EMBASE, and CINAHL were searched from inception to 14 February 2023. Backward citation tracking was performed. We included peer-reviewed, English language, systematic reviews and meta-analyses of randomized controlled trials (RCTs) and controlled clinical trials (CCTs) that compared exercise with conservative treatment, placebo or other exercise interventions in adults with musculoskeletal pain. Data were extracted from the following groups of reviews based on their reporting of exercise prescription data and analysis of the relationship between prescription variables and outcomes: (1) those that did not report any exercise prescription data, (2) those that reported exercise prescription data but did not perform a quantitative analysis and (3) those that performed a quantitative analysis of the relationship between exercise prescription variables and outcomes. Outcome measures were physical function, pain, mental health, adverse effects and adherence to treatment. AMSTAR-2 (A MeaSurement Tool to Assess systematic Reviews) was used to assess methodological quality. Results: From 6757 records, 274 systematic reviews were included. 6.6% of reviews did not report any exercise prescription data, and only 10.9% quantitatively analyzed the relationship between prescription variables and the outcome(s). The overall methodological quality was critically low in 85% of reviews. Conclusion: High methodological quality evidence is lacking for optimal exercise training prescription variables in individuals with musculoskeletal pain. To better inform practice and evidence gaps, future systematic reviews should (1) identify optimum exercise prescription variables, for example, via dose–response (network) meta-analysis, (2) perform high-quality reviews per AMSTAR-2 criteria and (3) include outcomes of mental health, adverse events and exercise adherence. PROSPERO registration number: CRD42021287440 (https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021287440).